<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Context-dependent hyperactivity in syngap1a and syngap1b zebrafish models of SYNGAP1-related disorder</title></titleStmt>
			<publicationStmt>
				<publisher>Frontiers Media S.A.</publisher>
				<date>07/10/2024</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10592640</idno>
					<idno type="doi">10.3389/fnmol.2024.1401746</idno>
					<title level='j'>Frontiers in Molecular Neuroscience</title>
<idno>1662-5099</idno>
<biblScope unit="volume">17</biblScope>
<biblScope unit="issue"></biblScope>					

					<author>Sureni H Sumathipala</author><author>Suha Khan</author><author>Robert A Kozol</author><author>Yoichi Araki</author><author>Sheyum Syed</author><author>Richard L Huganir</author><author>Julia E Dallman</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<sec><title>Background and aims</title><p>SYNGAP1-related disorder (SYNGAP1-RD) is a prevalent genetic form of Autism Spectrum Disorder and Intellectual Disability (ASD/ID) and is caused by<italic>de novo</italic>or inherited mutations in one copy of the<italic>SYNGAP1</italic>gene. In addition to ASD/ID, SYNGAP1 disorder is associated with comorbid symptoms including treatment-resistant-epilepsy, sleep disturbances, and gastrointestinal distress. Mechanistic links between these diverse symptoms and<italic>SYNGAP1</italic>variants remain obscure, therefore, our goal was to generate a zebrafish model in which this range of symptoms can be studied.</p></sec> <sec><title>Methods</title><p>We used CRISPR/Cas9 to introduce frameshift mutations in the<italic>syngap1a</italic>and<italic>syngap1b</italic>zebrafish duplicates (<italic>syngap1ab</italic>) and validated these stable models for Syngap1 loss-of-function. Because<italic>SYNGAP1</italic>is extensively spliced, we mapped splice variants to the two zebrafish<italic>syngap1a</italic>and<italic>b</italic>genes and identified mammalian-like isoforms. We then quantified locomotory behaviors in zebrafish<italic>syngap1ab</italic>larvae under three conditions that normally evoke different arousal states in wild-type larvae: aversive, high-arousal acoustic, medium-arousal dark, and low-arousal light stimuli.</p></sec> <sec><title>Results</title><p>We show that CRISPR/Cas9 indels in zebrafish<italic>syngap1a</italic>and<italic>syngap1b</italic>produced loss-of-function alleles at RNA and protein levels. Our analyses of zebrafish Syngap1 isoforms showed that, as in mammals, zebrafish Syngap1 N- and C-termini are extensively spliced. We identified a zebrafish<italic>syngap1</italic>α1-like variant that maps exclusively to the<italic>syngap1b</italic>gene. Quantifying locomotor behaviors showed that<italic>syngap1ab</italic>mutant larvae are hyperactive compared to wild-type but to differing degrees depending on the stimulus. Hyperactivity was most pronounced in low arousal settings, and hyperactivity was proportional to the number of mutant<italic>syngap1</italic>alleles.</p></sec> <sec><title>Limitations</title><p><italic>Syngap1</italic>loss-of-function mutations produce relatively subtle phenotypes in zebrafish compared to mammals. For example, while mouse<italic>Syngap1</italic>homozygotes die at birth, zebrafish<italic>syngap1ab−/−</italic>survive to adulthood and are fertile, thus some aspects of symptoms in people with<italic>SYNGAP1-</italic>Related Disorder are not likely to be reflected in zebrafish.</p></sec> <sec><title>Conclusion</title><p>Our data support mutations in zebrafish<italic>syngap1ab</italic>as causal for hyperactivity associated with elevated arousal that is especially pronounced in low-arousal environments.</p></sec>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>SYNGAP1-related disorder (SYNGAP1-RD), also known as SYNGAP1 syndrome, is caused by genetic variants in the SYNGAP1 gene and is one of the most prevalent genetic forms of intellectual disability (ID) <ref type="bibr">(Hamdan et al., 2010</ref><ref type="bibr">(Hamdan et al., , 2011;;</ref><ref type="bibr">Berryer et al., 2013;</ref><ref type="bibr">Satterstrom et al., 2020;</ref><ref type="bibr">Fu et al., 2022)</ref>. Since the first patient report in 2009, there are now about ~1,400 known SYNGAP1 patients worldwide, though with advocacy and awareness, these numbers continue to rise (curesyngap1.org; May 2024). While ID and epilepsy are the most penetrant symptoms, some people with SYNGAP1 RD also present with Autism Spectrum Disorder (ASD; ~50%), gastrointestinal distress (~68%), developmental delay, hypersensitivity to sound and light, high pain thresholds (~72%), and challenging behaviors that include increased risk-taking, aggression, and selfinjury (~73%) <ref type="bibr">(Pinto et al., 2010;</ref><ref type="bibr">Carvill et al., 2013;</ref><ref type="bibr">Kilinc et al., 2018;</ref><ref type="bibr">Weldon et al., 2018;</ref><ref type="bibr">Jimenez-Gomez et al., 2019;</ref><ref type="bibr">Vlaskamp et al., 2019;</ref><ref type="bibr">Naveed et al., 2023;</ref><ref type="bibr">omas et al., 2024)</ref>. e majority of SYNGAP1-RD-causing variants are de novo, occurring in the child but not in their parents <ref type="bibr">(Hamdan et al., 2010</ref><ref type="bibr">(Hamdan et al., , 2011;;</ref><ref type="bibr">Berryer et al., 2013)</ref>; SYNGAP1-RD is caused by haploinsufficiency, therefore, being heterozygous for a SYNGAP1 variant can be sufficient to cause symptoms, with the median age of seizure onset being two years <ref type="bibr">(Vlaskamp et al., 2019)</ref>.</p><p>To better understand genotype/phenotype relationships in SYNGAP1-RD, we generated loss-of-function mutations in zebrafish syngap1a and syngap1b duplicates using CRISPR/cas9 <ref type="bibr">(Varshney et al., 2016)</ref>. We focused on translationally-relevant phenotypes in six-day-old larvae that correspond to early childhood in people. With accessible early development, optically transparent embryos, high fecundity, and established methods for genetic manipulation, zebrafish complement extant rodent models to understand the role of disease genes in development and behavior <ref type="bibr">(Ijaz and Hoffman, 2016;</ref><ref type="bibr">Kozol et al., 2016;</ref><ref type="bibr">yme et al., 2019;</ref><ref type="bibr">Campbell et al., 2023;</ref><ref type="bibr">Weinschutz Mendes et al., 2023)</ref>. While mammals have a single SYNGAP1, zebrafish syngap1 is duplicated due to a whole genome duplication event 50-80 million years ago and retention of both syngap1a and syngap1b ohnologs <ref type="bibr">(Glasauer and Neuhauss, 2014;</ref><ref type="bibr">Kozol et al., 2016)</ref>. Two recent papers generated zebrafish syngap1b models that differ from the model we report here because they only target the "b" duplicate of the zebrafish syngap1 ohnologs <ref type="bibr">(Colon-Rodriguez et al., 2020;</ref><ref type="bibr">Griffin et al., 2021)</ref>.</p><p>Mammalian SYNGAP1 mRNAs are extensively spliced at N-and C-termini and the C-terminal isoforms &#945;1, &#945;2, &#946;, and &#947; have been functionally characterized <ref type="bibr">(Guo et al., 2009;</ref><ref type="bibr">McMahon et al., 2012;</ref><ref type="bibr">Araki et al., 2020;</ref><ref type="bibr">Kilinc et al., 2022)</ref>. e &#945;1 isoform is highly enriched at the post-synaptic density of glutamatergic synapses through a four amino-acid PDZ-interacting domain by which it interacts with the synaptic scaffolding protein PSD-95 <ref type="bibr">(Chen et al., 1998;</ref><ref type="bibr">Kim et al., 1998;</ref><ref type="bibr">Komiyama et al., 2002)</ref>. Here we annotate zebrafish mRNAs for how they might correspond to these mammalian isoforms and map zebrafish isoforms to syngap1a and syngap1b genes.</p><p>Individuals with SYNGAP1-RD show sensory hyperactivity, sometimes even seizures, in response to sensory stimuli such as eating, light, sound, touch, and/or pain <ref type="bibr">(Vlaskamp et al., 2019)</ref>. ese symptoms are a major concern of the SYNGAP1 parents and caregivers because they can put these individual's lives at risk <ref type="bibr">(Vlaskamp and Scheffer, 2020;</ref><ref type="bibr">Lyons-Warren et al., 2022)</ref>. Consistent with the human symptoms, rodent models also show sensory-induced hyperactivity as well as seizures that can be induced by loud sounds <ref type="bibr">(Guo et al., 2009;</ref><ref type="bibr">Ozkan et al., 2014;</ref><ref type="bibr">Michaelson et al., 2018;</ref><ref type="bibr">Creson et al., 2019;</ref><ref type="bibr">Sullivan et al., 2020)</ref>. To assess sensory-induced behaviors in syngap1ab zebrafish mutants, we used two standard sensorimotor assays: vibration to evoke the acoustic startle response (ASR) and transitions between light and dark to evoke the visual-motor response (VMR) <ref type="bibr">(Emran et al., 2008;</ref><ref type="bibr">Gao et al., 2014;</ref><ref type="bibr">Dunn et al., 2016)</ref>. Because changes to sensory habituation could contribute to sensory processing issues in SYNGAP1 patients <ref type="bibr">(Tavassoli et al., 2014;</ref><ref type="bibr">Robertson and Baron-Cohen, 2017;</ref><ref type="bibr">Oldehinkel et al., 2019)</ref>, we also conducted a short-term habituation assay to see how the syngap1ab zebrafish mutant larvae behave towards supra-threshold stimuli that are presented in rapid succession.</p><p>Like mammalian models, our zebrafish syngap1ab mutant models exhibit hyperactivity in both ASR and VMR assays. Hyperactivity was least pronounced in response to aversive acoustic stimuli and most pronounced during low-arousal light conditions. By analyzing the frequency distributions of movement distance and rest duration, we show that syngap1ab model hyperactivity in the light is due to higher-frequency, larger movements that resemble goal-directed behaviors associated with heightened states of arousal.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Fish maintenance and husbandry</head><p>All the zebrafish larvae and adults used in this study were reared at the University of Miami Zebrafish facility as per IACUC protocol #18-129. Water temperatures were maintained at 28&#176;C and both adult and larval zebrafish were exposed to a circadian cycle of 14 h light/10 h dark. Water housing adult zebrafish was continuously monitored for pH and conductivity to maintain conditions within an optimal range (pH 7-8.1; conductivity 350-800 mOsm). Upon collection, embryos were rinsed briefly in reverse osmosis water and reared in 10 cm petri dishes containing 'system water' (taken from water housing adults). Dishes were cleaned daily to remove unfertilized eggs and prevent fungal growth that could limit oxygen and stunt early embryonic growth. Larvae used for behavioral assays were raised ~50 larvae per petri dish to minimize competition and developmental delays.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CRISPR/Cas9 generation of syngap1ab mutant zebrafish</head><p>Syngap1ab mutants were generated using CRISPR/Cas9 genome editing technology <ref type="bibr">(Varshney et al., 2016)</ref>. One cell stage WT embryos were injected with small guide RNA (sgRNA; Integrated DNA Technologies-IDT Coralville IA) designed using CHOPCHOP online so ware <ref type="bibr">(Montague et al., 2014)</ref> to target exon 4 of syngap1a gene (400 pg) and exon 5 of syngap1b gene (400 pg), along with Cas9 protein (PNA Bio ousand Oaks CA; 100 pg). Embryos were either injected with syngap1a or syngap1b sgRNA using a foot-pedalcontrolled Milli-Pulse Pressure Injector (MPPI-3 from Applied Scientific Instrumentation ASI Eugene OR). Resulting mosaic F0 larvae were reared to adulthood and crossed to wild-type animals to generate an F1 generation for Sanger sequencing to identify syngap1a and syngap1b mutant alleles with indels resulting from CRISPR editing (see below). Upon identification of the mutant syngap1a and syngap1b alleles, adults were in-crossed to obtain syngap1ab double mutants. Adult syngap1ab mutant fish, used to spawn larvae for experiments, span F2-F5 generations. To obtain syngap1ab+/larvae, adult male syngap1ab-/-were outcrossed to WT (AB/TL, <ref type="url">https://zfin.org/action/genotype/view/ZDB-GENO-031202-1</ref>) females. To obtain syngap1ab-/-larvae, syngap1ab-/-adults were in-crossed. For simplicity, zebrafish that are heterozygous in both syngap1a and syngap1b genes are denoted as syngap1ab+/-, and those homozygous in both syngap1a and syngap1b genes are denoted as syngap1ab-/-. All the wild-type (WT) larvae used for this study were AB/TL unless otherwise stated and are denoted as syngap1ab+/+.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syngap1ab alleles used in this study</head><p>e molecular identity of CRISPR alleles was determined by obtaining a small caudal fin sample from each anesthetized (200 mg/L of Tricaine (MS-222)) F1 adult fish. Genomic DNA was extracted by digesting each fin sample in 50 &#956;L of 50 mM NaOH at 95&#176;C for 1 h, the HotSHOT method <ref type="bibr">(Samarut et al., 2016)</ref>. To determine larval genotypes, each larva was anesthetized by either placing them on ice for 30 min or by using 200 mg/L Tricaine (MS-222). Upon complete anesthetization, larval genomic DNA (gDNA) samples were isolated using the HotSHOT method, as detailed above but using only 20 &#956;L of 50 mM NaOH.</p><p>Gene-specific primers (Table <ref type="table">1</ref>) for both genes were designed using Primer3 so ware. Primer3 input sequences for each gene was selected based on their Cas9 target regions. For PCR, each reaction mixture contained 5 &#956;L of 10x GOTaq Polymerase (Promega Madison WI), 0.5 &#956;L from each 10 &#956;M forward primer and reverse primer, 3 &#956;L of nuclease-free water, and 1 &#956;L of gDNA (from either larvae or adultfin-clip digestions). Resulting PCR products were sent out for sequencing (Eurofins Genomics, LLC Louisville KY) and the results were read and analyzed using the ApE-A plasmid Editor v2.0.61 <ref type="bibr">(Davis and Jorgensen, 2022)</ref> and SnapGene viewer so ware to determine the syngap1a and syngap1b mutant alleles (Supplementary Figure <ref type="figure">S1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syngap1a and syngap1b isoform identification</head><p>To better characterize zebrafish syngap1ab splice variants, mRNA sequences (both published and predicted), were obtained from the NCBI protein database. To test for evidence of isoform expression, these sequences were searched against Expressed Sequence Tags (EST) and Transcriptome Shotgun Assembly (TSA) databases. Expressed isoforms were then BLASTed against the UCSC zebrafish genome browser to identify unique and common exons (Figure <ref type="figure">1</ref>).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>qPCR</head><p>To check for nonsense-mediated mRNA decay in syngap1ab mutants, qPCR was used to quantify relative syngap1ab expression levels in syngap1ab mutant larvae compared to WT larvae, both groups at 7 days post-fertilization (dpf). To extract RNA, larvae were anesthetized by placing them on ice for 30 min before using TRIzol (Life Technologies, Carlsbad, CA) following manufacturer's protocol. For each genotype (WT, syngap1ab+/-, and syngap1ab-/-), we conducted at least eight experimental replicates with 20 larvae pooled together per replicate. 1 &#956;g of RNA was used as input for RT-PCR. To enhance syngap1 cDNA in each sample, syngap1a and syngap1b gene-specific primers were used with Eukaryotic translation elongation factor 1 like 1 eef1a1l1 (ZFIN) as the internal control. cDNA was made using SuperScript III (Invitrogen&#8482;/ ermoFisher Scientific) and incubating at 50&#176;C for 1 h followed by 15 min at 70&#176;C. qPCR was carried out using GoTaq qPCR Probe Kit (Promega) in a QuantStudio3 RT-PCR system (Applied Biosystems&#8482;, Waltham MA) following manufacturer's protocol. Cycling conditions were as follows: Activation step of 95&#176;C for 10 min, followed by PCR with 40 cycles of 95&#176;C for 15 s and 60&#176;C for 1 min, followed by a melt curve of 95&#176;C for 15 s and 60&#176;C for 1 min. Relative levels of gene expression were calculated using the &#916;&#916;Ct method. For this method cycle threshold Ct values for syngap1a and syngap1b genes were first normalized to Ct values of the internal control eef1a1l1 by calculating &#916;Ct: Ct syngap1a -Ct eef1a1l1 and Ct syngap1b -Ct eef1a1l1 . Fold-changes in syngap1 gene expression were then compared in WT, syngap1ab+/-, and syngap1ab-/-larvae by calculating 2 -&#916;&#916;Ct with &#916;&#916;Ct:&#916;Ct syngap1ab mutant -&#916;Ct WT . Fold changes in syngap1ab mutants were calculated by dividing WT values. Group comparisons were made using 2-way ANOVA (gene and genotype) followed by Tukey's multiple comparison test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p>Brain regions (mouse) or whole brains (zebrafish) were excised from C57BL6 mice or adult zebrafish. Tissues were lysed in 10 volumes (for zebrafish, each brain was considered ~15 mg) of lysis buffer (50 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% TritonX-100, 0.2% SDS, 0.5% Sodium deoxycholate, with complete Protease inhibitor EDTA-free mix (Roche/MilliporeSIGMA Burlington MA)) using a Dounce homogenizer to obtain homogenized tissue samples. Each sample was then diluted by 1:10 using lysis buffer and ~ 20 &#956;L from each sample was loaded into each gel lane. Based on these experimental settings, each sample, i.e., for both zebrafish and mouse tissue samples, contained about 29 &#956;g of proteins per 20 &#956;L. Samples were first probed with SYNGAP1 antibodies (Abcam ab3344 or NOVUS nbp2-27541) and were followed by probing with secondary antibodies (anti-rabbit IgG IRDye680; LICOR 926-68071 or anti-goat IgG IRDye680; LICOR 926-68074). Resulting signals were measured and imaged using the fluorescence-based Odyssey CLx Imaging System (LICORbio Lincoln NE).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of syngap1a and syngap1b's relative importance for survival</head><p>To test for the potential effects of syngap1a and syngap1b mutant alleles on larval survival, three batches of syngap1ab+/-in-crosses were genotyped at six dpf. Data were analyzed using Prism GraphPad so ware (v9.1) to determine whether observed allele representation differed significantly from predicted using a Chi-square test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Short-term habituation assay</head><p>To test whether the larvae show habituation in response to acoustic stimuli, a short-term habituation assay was used as described in <ref type="bibr">Wolman et al. (2015)</ref>. A er 30 min of light adaptation, 6 dpf WT and syngap1ab+/-larvae were presented with 5 phases of acoustic stimulation using a DanioVision&#8482; observation chamber (Noldus Leesburg VA). Phase 1 consisted of 10 tap stimuli (intensity level 3) delivered at a 20 s inter stimulus interval (ISI). Phase 2 consisted of 10 tap stimuli (intensity level 5) delivered at also at a 20 s ISI. Phase 3, the habituation test, consisted of 30 tap stimuli (intensity level 5) delivered at 1 s ISI. Phase 4 was a 3 min rest period. Lastly phase 5 consisted of 10 tap stimuli (intensity level 5), delivered at a 20 s ISI. Total distance moved by each larva per second was analyzed to measure short-term habituation. Data were analyzed using Prism GraphPad so ware (v9.1) to compare WT and syngap1ab+/-groups using a 2-way ANOVA (Phase and Genotype) followed by a Tukey's multiple comparison test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Visual motor response (VMR) assay</head><p>Syngap1ab mutants and WT 6 dpf larvae larvae were placed in a 96-well plate containing system water. Prior to starting the experiment, larvae were dark adapted for 1 h and at 28&#176;C in the Noldus Sumathipala et al. 10.3389/fnmol.2024.1401746 Frontiers in Molecular Neuroscience 05 frontiersin.org</p><p>DanioVision&#8482; behavioral observation chamber. Ethovision &#174; XT 11 so ware (Noldus) was used to program the delivery of stimuli and to analyze the results. Images were captured at 40 Hz. For the visualmotor response (VMR) assay, larvae were exposed to 5 min of 12% (high-light settings) lights-on stimulus followed by 5 min of lights-off stimulus. Larval movements were recorded for four consecutive light on/off cycles and their activity/movements were recorded for a total duration of 40 min. Larvae were then genotyped using the genotyping assays previously described and analyzed for the total distance moved/ time. e resulting data were further analyzed using GraphPad Prism 9.1 so ware to compare WT, syngap1ab+/-, and syngap1ab-/groups using Kruskal-Wallis ANOVA followed by Dunn's multiple comparison tests.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Displacement and dwell-time analyses</head><p>To test whether the observed hyperactivity is due to increased initiation of movements or increased distance moved, the displacement and dwell-time data from raw, exported data produced by Ethovision &#174; XT 11 so ware were analyzed using MATLAB scripts 1 to examine behavioral probability distributions. Resulting data were plotted using Prism GraphPad (V9.1) and WT and syngap1ab groups compared using a two-sample Kolmogorov-Smirnov test.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>Zebrafish syngap1b but not syngap1a encodes an isoform that is similar to the mammalian PDZ-interacting Syngap1&#945;1</p><p>While mammals including humans have a single SYNGAP1 gene that encodes a 1,343 amino acid, ~149 kDa protein <ref type="bibr">(Komiyama et al., 2002)</ref>, there are two syngap1 ohnologs present in the zebrafish genome. e zebrafish syngap1a gene is found on chromosome 16 and encodes a 1,290 amino acid, ~146 kDa protein whereas the syngap1b gene is found on chromosome 19 and encodes a 1,507 amino acid, ~160 kDa protein. Like rodents and humans, both zebrafish Syngap1a and Syngap1b have four, highly conserved protein-protein interacting domains: pleckstrin homology (PH), C2, RasGAP, and coiledcoiled (CC).</p><p>We characterized zebrafish Syngap1 isoforms based on NCBI databases and comparisons to mammalian isoforms. In mammalian Syngap1, there are four well-characterized, alternatively-spliced Syngap1 isoforms, &#945;1, &#945;2, &#946;, and &#947;, that vary at their C-termini <ref type="bibr">(McMahon et al., 2012)</ref>. To assess whether zebrafish syngap1a and syngap1b genes might encode similar isoforms, we curated all published and predicted syngap1ab isoforms. Similar to the mammalian isoforms, for both zebrafish syngap1a and syngap1b genes, exons encoding the four protein interaction domains occur in all isoforms with many alternative exons at both N-and C-termini. Based on expressed sequence databases, we were able to identify five syngap1a and eleven syngap1b isoforms (Figure <ref type="figure">1</ref>). Of 1 <ref type="url">https://github.com/sheyums/Sureni_Sumathipala_syngap1.git</ref> the human C-term isoforms, &#945;1 is the most studied and is localized to the post-synapse by a four amino acid (QTRV) PDZ-interacting domain. Interestingly, we were able to find a zebrafish syngap1b C-term isoform X5 with a putative mammalian-like PDZ-interacting domain that had ten of eleven of the terminal amino acids identical to those of the human SYNGAP1 &#945;1 isoform (Figure <ref type="figure">1B</ref>). We were unable to find mammalian-like isoforms (&#945;2, &#946;, and &#947;) due to the highly variable C-terminal ends in the zebrafish isoforms.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CRISPR/Cas9-generated alleles produce loss-of-function SYNGAP1 models</head><p>To better understand how pathogenic mutations in syngap1 result in altered behaviors, we used CRISPR/Cas9 to generate zebrafish loss-of-function mutations. In humans, pathogenic variants span the SYNGAP1 gene <ref type="bibr">(Hamdan et al., 2011;</ref><ref type="bibr">Berryer et al., 2013;</ref><ref type="bibr">Vlaskamp et al., 2019;</ref><ref type="bibr">Gamache et al., 2020)</ref>. To mutate a region of the gene that would affect the majority of isoforms, we targeted the earliest shared exons, exon 4 and exon 5 in syngap1a and syngap1b respectively, to generate loss-of-function alleles. CRISPR/Cas9 induces indels causing reading frame shi s and introducing premature stop codons. Upon sequence analyses of F1 adult crispants, we selected two mutant alleles for syngap1a (syngap1a + 7 nucleotide insertion and syngap1a -22 nucleotide deletion) and one allele for syngap1b with a -14 nucleotide deletion, all of which would be predicted to result in a severely truncated proteins that were less than 200aa (Figure <ref type="figure">2B</ref>). To best recapitulate human SYNGAP1 variant haploinsufficiency, we used double-heterozygous larvae for syngap1a + 7 and syngap1b -14, and to further assess complete loss-of-function, we used doublehomozygous larvae (here onwards denoted as syngap1ab+/-and syngap1ab-/-respectively).</p><p>We tested for loss-of-function of syngap1 at the level of protein and mRNA. Western blot analysis carried out using adult zebrafish brain lysates showed reduced Syngap1 protein levels in syngap1ab-/-brain tissues (Figure <ref type="figure">2C</ref>). qPCR analysis of RNA harvested from 7-day-old larvae showed reduced RNA transcripts in both syngap1ab+/-(adjusted p values for syngap1a = 0.001, and syngap1b = 0.0495) and syngap1ab-/-(adjusted p values for syngap1a = 0.0699 and syngap1b = 0.0312) mutant larvae compared to WT larvae supporting non-sense mediated decay (Figure <ref type="figure">2D</ref>). Taken together, these results show that our CRISPR/cas9 generated Syngap1ab zebrafish mutants show reduced mRNA and protein expression, supporting the use of these alleles as haploinsufficient models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evidence for functional complementarity between syngap1a and syngap1b genes</head><p>To study potential interactions between Syngap1a and Syngap1b proteins, we analyzed larval survival from each of the nine genotypes resulting from syngap1ab+/-in-crosses. When syngap1b mutant alleles outnumbered syngap1a mutant alleles, larval survival was much lower than expected (Supplementary Figures <ref type="figure">S2A</ref>,<ref type="figure">B</ref>; p &lt; 0.0001). By contrast, zebrafish in which there were more syngap1a than syngap1b mutant alleles were over-represented and zebrafish in which there were an equal number of syngap1a and syngap1b mutant alleles were as expected. ese observations suggest that each ohnolog contributes</p><p>10.3389/fnmol.2024.1401746 Frontiers in Molecular Neuroscience 06 frontiersin.org</p><p>distinct functional roles so that the syngap1a ohnolog, likely due to its inability to encode the Syngap1 &#945;1 isoform, cannot make up for loss of syngap1b ohnolog.</p><p>Syngap1ab+/-larvae show greater dynamic range, elevated response probability, and normal habituation in response to acoustic stimuli</p><p>Given that SYNGAP1 is known to be important for sensory processing, we wanted to test the dynamic range of syngap1ab+/-zebrafish responses to vibration stimuli of medium and high intensity as well as their ability to habituate to repeated, highintensity, high-frequency stimuli. To assess these factors, we used an assay described in <ref type="bibr">Wolman et al. (2015)</ref> in which 6 days-postfertilization (dpf) larvae were exposed to different intensity vibrations with different inter-stimulus intervals (ISIs) during phases 1-5 of the assay (Figure <ref type="figure">3A</ref>). We allowed larvae to acclimate to the Noldus chamber for 30 min before exposing them to vibrational stimuli. During phases 1 and 2, 10 taps of medium-intensity (level 3) and highintensity (level 5) respectively were delivered with 20 s ISI. During phase 3, habituation was tested by delivering 30 high-intensity taps with 1 s ISI. is was followed by a 3 min rest period in phase 4. Resulting CRISPR mutants used for phenotypic analyses: syngap1a 1 allele p.Ser43Argfs*21 and syngap1b allele p.Met149Ilefs*9. syngap1a 1 had an amino acid change from a serine to an arginine at position 43 introducing a premature stop codon, 21 amino acids downstream. Syngap1b mutant allele had a change of methionine to an isoleucine at position 49 introducing a premature stop codon 9 amino acids downstream. (C) Western blots illustrate the expression of SYNGAP1 in whole brain lysates from adult mice and zebrafish. In wild-type zebrafish, the Syngap1 protein was detected at a similar molecular weight (~150 kDa) to that of the mouse SYNGAP1, using a rat anti-Syngap1 antibody. GAPDH and tubulin were used as the loading controls for mouse and zebrafish, respectively. (D) Mutant syngap1ab larvae showed reduced syngap1a and syngap1b mRNA expression levels at 7dpf. Group comparisons were made using 2-way ANOVA followed by Tukey's multiple comparison test. Finally, phase 5 was a repeat of phase 2 with 10 high-intensity taps delivered with 20 s ISI. Overall, syngap1ab+/-larvae (n = 130 from 3 independent crosses) responded very similarly to WT larvae (n = 110 from three independent crosses) (Figure <ref type="figure">3B</ref>), with a normal degree of habituation to high frequency stimuli (Figure <ref type="figure">3C</ref>). Despite these similarities, there were subtle differences. syngap1ab+/-larvae showed consistently elevated responses to highintensity stimuli during phases 2 and 5. To determine whether this was due to larger movements and/or an increased probability of response, we calculated median movement velocity per larva (Figure <ref type="figure">3D</ref>) and their response probability (Figure <ref type="figure">3E</ref>) during Phases 1, 2, and 5. For median movement velocity (calculated across taps in a given phase), a mixed effects model of phase and genotype indicated a significant effect of phase (p = 0.0018).</p><p>e subsequent Tukey's multiple comparison test showed that syngap1+/-larvae moved further in response to high-intensity vibrations in phases 2 and 5 than to 10.3389/fnmol.2024.1401746 Frontiers in Molecular Neuroscience 08 frontiersin.org</p><p>medium-intensity vibrations in phase 1 (p = 0.0006 and 0.0007 respectively) while WT larvae moved similar distances during phases 1, 2, and 5. For probability of response, a mixed effects model indicated effects of both phase (p &lt; 0.0001) and genotype (p = 0.0009). e subsequent Tukey's multiple comparison test showed that syngap1+/larvae had a higher response probability to stronger vibrational stimuli (p &lt; 0.0001 Phase 1 vs. 2; p = 0.0002 Phase 1 vs. 5) and that this higher response probability to high-intensity stimuli was greater in syngap1+/-than WT larvae (p = 0.0049 Phase 2; p = 0.0014 Phase 5). erefore, in response to stronger stimuli, syngap1+/-are more likely to move and move faster, indicating a larger dynamic range of response in syngap1+/-larvae. is higher probability of response to the same stimulus is also consistent with higher levels of arousal in syngap1+/-larvae.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Syngap1ab mutant hyperactivity is most pronounced in low-arousal settings</head><p>We next assessed visual-motor responses (VMR) <ref type="bibr">(Burgess and Granato, 2007;</ref><ref type="bibr">Emran et al., 2008)</ref> in the syngap1ab models. For this assay, larval movements were recorded during four cycles of lights-on to lights-off transitions. Larval activity was measured as the total distance moved every 30 s. Larvae show robust increases in locomotor activity when presented with a sudden transition from light to darkness (Supplementary Figure <ref type="figure">S3</ref>; Figure <ref type="figure">4A</ref>). Compared to WT larvae, both syngap1ab+/-and syngap1ab-/-larvae showed increased activity (p &lt; 0.0001) during both lights-on and lights-off cycles (Figure <ref type="figure">4B</ref>). During lights-off periods syngap1ab+/-showed the greatest movement but this trend was somewhat variable across batches of larvae (Supplementary Figure <ref type="figure">S3B</ref>); during lights-on, hyperactivity was consistent across batches of larvae and was dependent on the number of mutant syngap1 alleles with syngap1ab-/-showing the greatest movement (Figure <ref type="figure">4</ref>; Supplementary Figure <ref type="figure">S3</ref>).</p><p>For the preceding assays, WT, syngap1ab+/-, and syngap1ab-/larvae resulted from independent crosses. To rule out the influence of distinct parental genetic backgrounds on the observed behavior, we also examined VMR in larvae resulting from an in-cross between syngap1ab+/-adults (Supplementary Figures <ref type="figure">S2C</ref>,<ref type="figure">D</ref>). Consistent with the previous results, during both lights-on (Supplementary Figure <ref type="figure">S2C</ref>) and lights-off cycles (Supplementary Figure <ref type="figure">S2D</ref>), syngap1ab-/-had the highest activity levels among all the resulting genotypes.</p><p>Syngap1ab hyperactivity in the light resembles WT behavior in the dark e hyperactivity we observed in the syngap1ab mutant models could be due to either increased movement frequency, increased distance traveled per movement, or both. To distinguish among these possibilities, we analyzed the larval movement at a higher temporal resolution. Data were sampled every 25 ms, a much higher temporal resolution than the distance per 30 s shown in the preceding figures. Zebrafish movement bouts last ~250 ms and so 40 Hz resolution is sufficient to capture the majority of bouts with multiple timepoints. We focused on two parameters: the time interval between two consecutive movement bouts, denoted as "dwell time, " and the distance traveled per bout, denoted as "displacement. " ese highresolution activity data were organized and analyzed using customwritten MATLAB scripts to assess the probability of different behaviors, described by displacement and dwell time, during light and dark conditions.</p><p>Given highly stochastic individual larval movements, to assess overall patterns of both high and low frequency events across the distribution, we captured a large number of data points from over 100 individuals per genotype and then divided the total bouts by the number of individuals to generate and "idealized larva" for each genotype (Figures <ref type="figure">4B</ref>,<ref type="figure">C</ref>). When bouts were pooled across individuals of a genotype, there were &gt; 10 5 bouts per genotype and light condition (Lights-On: WT n = 119,135, syngap1ab+/-n = 196,594, and syngap1ab-/-n = 158,443; Lights-Off: WT n = 652,368, syngap1ab+/n = 777,525, and syngap1ab-/-n = 507,720) coming from 173 WT, 167 syngap1ab+/-, and 119 syngap1ab-/-individual larvae. is analysis shows that the differences between genotypes are much more pronounced in the light/low arousal settings, than in the dark/higher arousal setting.</p><p>We next looked at probability distributions of dwell times (the time between movements) and distance traveled per movement (Figure <ref type="figure">5</ref>). WT larvae in the dark had shorter dwell times and larger movements than WT in the light (Figures <ref type="figure">5Ai</ref>,<ref type="figure">ii</ref>). These differences in WT light and dark behaviors are highlighted by plots below that show the relative probabilities in Dark versus Light for both dwell time and displacements <ref type="bibr">(Figures 5Aiii,</ref><ref type="bibr">iv)</ref>. Next, we compared syngap1ab+/-and WT in the light (Figure <ref type="figure">5B</ref>) and in the dark (Figure <ref type="figure">5C</ref>). In the dark, syngap1ab+/-and syngap1ab-/-had dwell time and displacement distributions that were very similar to WT larvae . By contrast, in the light, syngap1ab-/-and syngap1ab+/-mutants displayed both more frequent, and larger displacements compared to WT larvae (Figures <ref type="figure">5Bi</ref>,<ref type="figure">ii</ref>). These differences between syngap1+/-and WT larvae in the light are highlighted by plots below that show the relative probabilities of syngap1+/-(purple) and syngap1-/-(pink) versus WT <ref type="bibr">(Figures 5Biii,</ref><ref type="bibr">iv)</ref>. These analyses showed that syngap1-WT (in light) resembles dark-light WT comparisons, indicating that syngap1 mutants behavior in the light resembles that of WT behavior in the dark. Taken together, behavioral experiments show context-dependent hyperactivity that is most subtle during aversive, acoustic stimuli, is intermediate in the dark, and is most pronounced in normally low arousal well-lit environments.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>In this study, we generated a zebrafish model of SYNGAP1-RD and characterized zebrafish syngap1ab splice-variants as they relate to mammalian Syngap1 and zebrafish syngap1a and syngap1b duplicates.</p><p>is provided background for the stable zebrafish mutant model of SYNGAP1-RD we generated using CRISPR/cas9 genome editing of both syngap1a and synagp1b duplicates; mutations were validated as loss-of-function alleles at both mRNA and protein levels. We provide evidence that syngap1a and syngap1b play complementary functional roles in zebrafish with higher larval mortality when syngap1b mutant alleles outnumber those from syngap1a. Focusing on balanced syngap1a and syngap1b mutant genotypes for more detailed analyses,</p><p>10.3389/fnmol.2024.1401746 Frontiers in Molecular Neuroscience 09 frontiersin.org</p><p>we showed that, as in mammalian models and humans, the zebrafish syngap1ab models show context-dependent hyperactivity that is especially pronounced in low arousal settings. Similar to mammalian Syngap1 isoforms <ref type="bibr">(Gou et al., 2020;</ref><ref type="bibr">Yang et al., 2023)</ref>, both Syngap1 zebrafish orthologs show extensive splicing at both N-and C-termini as well as splice-variants in the middle of the gene that only change a few amino acids. We provide evidence that syngap1b but not the syngap1a encodes an &#945;1-like isoform, the most extensively studied of the mammalian Syngap1 isoforms <ref type="bibr">(Chen et al., 1998;</ref><ref type="bibr">Kim et al., 1998;</ref><ref type="bibr">Walkup et al., 2016;</ref><ref type="bibr">Araki et al., 2020)</ref>. In mammals, the &#945;1 isoform has been shown to be enriched at the postsynaptic density of glutamatergic synapses by interacting with PSD-95 <ref type="bibr">(Chen et al., 1998;</ref><ref type="bibr">Kim et al., 1998;</ref><ref type="bibr">Komiyama et al., 2002)</ref>. In mice, loss of the &#945;1 isoform alone is sufficient to produce cognitive deficits and seizures <ref type="bibr">(Kilinc et al., 2022)</ref>. e &#945;1 isoform is also critical for long-term-potentiation-based forms of learning, toggling the strength of the synapse in an activity-dependent manner by competing with AMPA glutamate receptors for PSD95 binding sites <ref type="bibr">(Araki et al., 2024)</ref>. e unique expression of the Syngap1 &#945;1 isoform by the syngap1b gene may help to explain higher mortality in zebrafish larvae with more syngap1b than syngap1a mutant alleles. We were not able to determine which of the zebrafish splice-variants corresponded to the other well-characterized mammalian Syngap1 &#945;2, &#946;, and &#947; isoforms <ref type="bibr">(Kilinc et al., 2018;</ref><ref type="bibr">Araki et al., 2020;</ref><ref type="bibr">Gou et al., 2020)</ref>, due to sequence divergence in the zebrafish consistent with differences that have been previously described in the zebrafish synapse proteome <ref type="bibr">(Bayes et al., 2017)</ref>.</p><p>Other zebrafish models of SYNGAP1-RD mutated only the syngap1b gene <ref type="bibr">(Colon-Rodriguez et al., 2020;</ref><ref type="bibr">Griffin et al., 2021)</ref>. Our differential survival results would predict that the phenotypes reported in syngap1b models may relate to a functional imbalance between syngap1a and syngap1b. Our more in-depth subsequent analyses, Syngap1 model hyperactivity is most pronounced during light cycles due to a higher frequency of larger movements. (A) Median &#177; 95% confidence interval distance moved by each 6 dpf larva per 30 s, when exposed to 5 min of lights-on and 5 min of lights-off alternating cycles across five different independent trials (Supplementary Figure <ref type="figure">S3</ref>). (B) During lights-on cycles, syngap1ab mutants showed increased activity levels in a genotype dependent manner where syngap1ab-/-were more active than syngap1ab+/-which were more active than the WT larvae. During lights-off cycles, syngap1ab mutant larvae showed significantly increased activity compared to WT larvae but there were no significant differences in the activity levels between syngap1ab-/-and syngap1ab+/-larvae. Statistical analyses between genotypes were carried out using Kruskal-Wallis test followed by therefore, focused on larvae with balanced heterozygous mutations in both syngap1a and syngap1b in an effort to recapitulate mammalian haploinsufficiency.</p><p>In humans, altered sensory processing encompasses sensory hyperactivity/ hypoactivity and sensory seeking, and is a core symptom of an ASD diagnosis <ref type="bibr">(Marco et al., 2011;</ref><ref type="bibr">Kirby et al., 2017;</ref><ref type="bibr">Robertson and Baron-Cohen, 2017;</ref><ref type="bibr">Damiano-Goodwin et al., 2018)</ref>. In SYNGAP1-RD specifically, sensory-seeking behaviors include an affinity for contact with flowing water and/or perpetual motion <ref type="bibr">(Wright et al., 2022)</ref>. Syngap1 haploinsufficiency in both mice and humans alters sensory responses in a way that is context dependent, impacting simple sensory responses, entrainment, and habituation <ref type="bibr">(Carreno-Munoz et al., 2022)</ref> and causing increased risk-taking behaviors <ref type="bibr">(Kilinc et al., 2018;</ref><ref type="bibr">Weldon et al., 2018)</ref>. Further studies on sleep in people with SYNGAP1-RD <ref type="bibr">(Smith-Hicks et al., 2021)</ref> and mouse models, show Syngap1ab mutants showed heightened arousal during lights-on cycles with more frequent and larger displacements. (Ai,ii) Probability distributions of dwell times (Ai) and displacements (Aii) are plotted for all 173 WT(syngap1ab+/+) larvae during lights-on (yellow) and lights-off (dark; checkered) cycles. Below (Aiii,iv) compare movements in dark and light by plotting probability in dark minus the probability in light. WT larvae moved farther more frequently in dark than in light. (B,C) Probability distributions of dwell time (Bi, Ci) and displacements (Bii, Cii) are plotted for all 173 WT, 167 syngap1ab+/-and 119 syngap1ab+/-mutant larvae. Below probability distribution plots (Biii,iv, Ciii,iv) compare movements in syngap1ab+/-(purple) and syngap1ab-/-(pink) to WT (black) by plotting probability in syngap1ab mutants minus the probability in WT. In dark, syngpa1ab+/-larvae moved more frequently than either WT or syngap1ab-/-larvae while all genotypes had similar displacement distributions. By contrast, in light, both syngpa1ab+/-and syngap1ab-/-larvae moved more frequently and farther than WT following a similar pattern that WT larvae showed during dark periods. p values were calculated using two-sample Kolmogorov-Smirnov test and for lights-on displacement: p(WT vs. syngap1ab+/-) = 0, p(WT vs. syngap1ab-/-) = 0, and p(syngap1ab+/-vs. syngap1ab-/-) = p &lt; 10 -70 and during lights-off displacement; p(WT vs. syngap1ab+/-) = 10 -26 , p(WT vs. syngap1ab-/-) = 1.5&#215;10 -11 , and p(syngap1ab+/-vs. syngap1ab-/-) = p &lt; 10 -45 , lights-on dwell time (WT vs. syngap1ab+/-) = 0, p(WT vs. syngap1ab-/-) = 0, and p(syngap1ab+/-vs. syngap1ab-/-) = p &lt; 10 -31 and lights-off dwell time; p(WT vs. syngap1ab+/-) = 10 -200 , p(WT vs. syngap1ab-/-) = 10 -50 , and p(syngap1ab+/-vs. syngap1ab-/-) = p &lt; 10</p><p>-200 . 10.3389/fnmol.2024.1401746 Frontiers in Molecular Neuroscience 11 frontiersin.org disrupted sleep and seizures that are more common at night and o en come in clusters that predict transitions between REM and non REM sleep <ref type="bibr">(Sullivan et al., 2020)</ref>. Taken together, this collection of symptoms is consistent with a heightened state of arousal and difficulties with behavioral state transitions in people with SYNGAP1-RD. Similar to mammalian SYNGAP1-RD models, our syngap1ab zebrafish mutant models exhibit context-dependent hyperactivity. In high arousal contexts generated by strong, aversive acoustic stimuli, WT and syngap1+/-larvae produced similar highlystereotyped, high-velocity escape responses, related to startle responses in mammals by their short latency from the stimulus and their dependence on reticulospinal neurons <ref type="bibr">(Liu and Fetcho, 1999;</ref><ref type="bibr">Eaton et al., 2001;</ref><ref type="bibr">Korn and Faber, 2005)</ref>. In contrast to WT, syngap1ab+/-larvae had a larger dynamic range of responses compared to WT. Larger displacements in response to aversive, acoustic stimuli have been described in zebrafish glucocorticoid receptor mutants that have chronically elevated glucocorticoids due to a lack of feedback inhibition <ref type="bibr">(Griffiths et al., 2012)</ref>. Unlike glucocorticoid receptor mutants however, our syngap1ab+/-model also moves faster and more frequently in the light. erefore, syngap1ab+/-hyperactivity likely involves other arousal pathways.</p><p>In both mammals and zebrafish, arousal pathways including dopamine, QRFP, serotonin, and hypocretin/orexin among others have been linked to increased locomotion <ref type="bibr">(Chiu and Prober, 2013;</ref><ref type="bibr">Lovett-Barron et al., 2017;</ref><ref type="bibr">Corradi and Filosa, 2021;</ref><ref type="bibr">Tan et al., 2022)</ref>. Moreover, gain-of-function experiments in zebrafish have shown that overexpressing either hypocretin/orexin or CART (cocaine and amphetamine regulated transcript) is sufficient to increase the probability that zebrafish larvae will respond to acoustic stimuli <ref type="bibr">(Prober et al., 2006;</ref><ref type="bibr">Woods et al., 2014)</ref>; and overexpression of any one of hypocretin/orexin, calcitonin gene related peptide (cgrp), or cholecystokinin (cck) is sufficient to increase daytime movement frequencies <ref type="bibr">(Woods et al., 2014)</ref>. us, overactivation of select arousal pathways is consistent with syngap1ab+/-hyperactivity.</p><p>We found that syngap1+/-hyperactivity was greatest in the light, a setting characterized by low arousal, long dwell times and short movements in WT larvae. Both syngap1ab+/-and syngap1ab-/larvae exhibited short dwell times and large movements, similar to WT movements when they are suddenly transitioned to the dark <ref type="bibr">(Burgess and Granato, 2007;</ref><ref type="bibr">Emran et al., 2008;</ref><ref type="bibr">Kozol et al., 2021)</ref>. Increased WT movements with sudden darkness have been shown to reflect a goal-directed, light-seeking behaviors also known as dark phototaxis <ref type="bibr">(Horstick et al., 2017)</ref>. Goal-directed increases in activity can also result from internal states, such as hunger, studied in 7-dayold zebrafish larvae that no longer have a yolk supply <ref type="bibr">(Filosa et al., 2016;</ref><ref type="bibr">Wee et al., 2019)</ref>. In this study, hyperactive syngap1ab mutants were 6-day-olds and therefore their hyperactivity was not likely to be driven by hunger. Hunger-induced hyperactivity is associated with reduced cortisol, increased activity in the serotonergic raphe neurons and increased risk-taking as larvae approach objects that could be either food items or predators <ref type="bibr">(Filosa et al., 2016)</ref>. Like hunger, flowing water can also evoke more frequent movements that are dependent upon serotonergic dorsal raphe serotonergic pathways <ref type="bibr">(Yokogawa et al., 2012)</ref>. It is possible that the hyperactivity that we observe in the syngap1ab+/-larvae in low arousal settings is a form of sensory-seeking behavior.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p>Zebrafish are less affected by Syngap1 loss-of-function than mammals.</p><p>is difference suggests that phenotypes in zebrafish syngap1ab mutants might be less pronounced than symptoms in people with SYNGAP1-RD. Milder phenotypes in zebrafish than in mammals have been observed in several mutant models that affect synapses <ref type="bibr">(Ono et al., 2001</ref><ref type="bibr">(Ono et al., , 2002;;</ref><ref type="bibr">Mongeon et al., 2008;</ref><ref type="bibr">Wang et al., 2008)</ref>. One of the reasons for this is that at the time they are undergoing bursts of synaptogenesis, around birth in mice and around 3 dpf in zebrafish, they are vastly different sizes. Due to their relatively small size, zebrafish larvae do not need to breathe to supply their tissues with oxygen. For example, it is possible to generate a healthy, paralyzed, transparent zebrafish larva for in vivo imaging of physiological processes such as angiogenesis <ref type="bibr">(Davis et al., 2021)</ref> because simple oxygen diffusion is sufficient to support oxidative processes. By contrast, in mice, the same mutations would prove lethal at birth when the pups have to breathe to provide oxygen to their tissues. ese differences may help to explain why mutations in similar genes can be viable in the zebrafish model but more severe and/or lethal in the mammalian models.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p>Studies in people with diverse genetic forms of neurodevelopmental conditions and in animal models show that, despite some shared aspects of etiology, including changes to neuro-and gliogenesis and altered excitatory/inhibitory balance <ref type="bibr">(Hoffman et al., 2016;</ref><ref type="bibr">Willsey et al., 2021)</ref>, detailed changes in neuroanatomy, behavioral profiles, and associated symptoms exhibit substantial differences by genotype supporting the existence of subtypes <ref type="bibr">(Ellegood et al., 2015;</ref><ref type="bibr">yme et al., 2019;</ref><ref type="bibr">Zerbi et al., 2021;</ref><ref type="bibr">Zoodsma et al., 2022;</ref><ref type="bibr">Weinschutz Mendes et al., 2023)</ref>. In the case of SYNGAP1, both human and animal model studies point to arousal pathways as playing an important role in context-dependent hyperactivity.</p><p>ese condition-specific phenotypes can serve as the basis for the development of precision therapies in animal models like zebrafish that are suited to highthroughput, high-content screening <ref type="bibr">(Hoffman et al., 2016)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data availability statement</head><p>e datasets presented in this study can be found in online repositories. e names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.</p><p>Ethics statement e animal study was approved by University of Miami IACUC protocol #18-129. e study was conducted in accordance with the local legislation and institutional requirements.</p></div></body>
		</text>
</TEI>
